Ignite Creation Date:
2024-05-05 @ 11:24 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00020644
Status:
UNKNOWN
Last Update Posted:
2013-08-07
First Post:
2001-07-11
Brief Title:
Continuous Infusion Gemcitabine in Treating Patients With Advanced Metastatic Cancer
Sponsor:
Advocate Lutheran General Hospital
Organization:
National Cancer Institute NCI
Organization Data
Organization:
National Cancer Institute NCI
Class:
NIH
Study ID:
LGH-3000
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Advocate Lutheran General Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None